SOPHiA GENETICS SA Net Income 2020-2025 | SOPH

SOPHiA GENETICS SA net income from 2020 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
SOPHiA GENETICS SA Annual Net Income
(Millions of US $)
2024 $-62
2023 $-79
2022 $-87
2021 $-74
2020 $-39
2019 $-34
SOPHiA GENETICS SA Quarterly Net Income
(Millions of US $)
2025-03-31 $-17
2024-12-31 $-15
2024-09-30 $-18
2024-06-30 $-15
2024-03-31 $-14
2023-12-31 $-24
2023-09-30 $-14
2023-06-30 $-21
2023-03-31 $-20
2022-12-31 $-14
2022-09-30 $-23
2022-06-30 $-25
2022-03-31 $-25
2021-12-31 $-21
2021-09-30 $-21
2021-06-30 $-18
2021-03-31 $-13
2020-12-31 $-10
2020-09-30 $-10
2020-06-30 $-8
2020-03-31 $-11
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.195B $0.065B
SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.234B 52.81
Hims & Hers Health (HIMS) United States $12.982B 134.88
Tempus AI (TEM) United States $10.012B 0.00
IRhythm Technologies (IRTC) United States $4.465B 0.00
Inspire Medical Systems (INSP) United States $4.309B 67.32
Privia Health (PRVA) United States $2.902B 198.33
Enovis (ENOV) United States $1.848B 10.30
Clover Health Investments (CLOV) United States $1.791B 0.00
Schrodinger (SDGR) United States $1.498B 0.00
Phreesia (PHR) United States $1.456B 0.00
Omnicell (OMCL) United States $1.281B 22.59
Azenta (AZTA) United States $1.258B 58.47
10x Genomics (TXG) United States $1.024B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Talkspace (TALK) United States $0.486B 145.25
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.473B 0.00
Standard BioTools (LAB) United States $0.395B 0.00
TruBridge (TBRG) United States $0.363B 805.00
Nyxoah SA (NYXH) Belgium $0.274B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
EUDA Health Holdings (EUDA) Singapore $0.141B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.086B 3.27
111 (YI) China $0.067B 0.00
Outset Medical (OM) United States $0.067B 0.00
P3 Health Partners (PIII) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00